Delivery Order SPE2DB20D3103-SPE2DB25FN2K4

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,177.21, is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,784.85, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has a firm fixed price pricing type and a period of performance through February 20, 2024. This delivery order is issued under AmerisourceBergen's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.50, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of January 30, 2025. This award is not associated with a set-aside designation. In addition to this specific delivery order,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.08, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 23, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,694.48, is for the delivery of 4564043125 - Fluticasone Prop HFA 44 MCG 10.6GM to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,577.18 firm fixed-price contract is for the delivery of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,855.98 firm-fixed-price contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has a performance period through June 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,019.36 firm fixed-price contract is for the supply of 4,565,302,600 units of Fluticasone Prop HFA 220 MCG 12GM, a respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,564,184,313 units of Fluticasone Prop HFA 110 MCG 12GM. The $3,843.09 firm-fixed-price contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
This is a $4,705.06 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a performance period through May 2, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN2K4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.97 firm-fixed-price contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/27/25, 12:03 PM